CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 78 enrolled
Drug / intervention
Gabapentin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03472521
NCT03472521Phase 4Completed
CompareCT.gov

Prevention of Persistent Pain and Opioid Use in Mothers - POMS

Stanford University·interventional·Posted Mar 21, 2018·Updated May 5, 2022

In Brief

A Phase 4 clinical trial evaluating Gabapentin and Placebo for Opioid Use and 2 related conditions. Completed, enrolled 78 participants across 1 site.

Detailed Summary

Our previous work has identified the group of women at risk for prolonged pain, opioid use and poor functional recovery after childbirth. The optimal intervention to mitigate this risk is unknown. We propose to test an analgesic adjutant that is commonly used for post-operative pain compared to placebo to improve post-partum recovery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid Use, Postpartum Disorder, Chronic Pain Syndrome
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedMar 21, 2018
Enrollment StartSep 17, 2018
Primary CompletionJul 2, 2020
Study CompletionApr 10, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.3 years ago

Interventions

Gabapentindrug

Treatment with analgesic adjutant commonly used for post-operative pain, titrated to effect by chronic pain specialist compared to placebo titration.

Placebodrug

Placebo to match gabapentin